| Page 148 | Kisaco Research

Animal health is moving from occasional clinic visits to connected, everyday care.

For COMPANION animals, AI (Artificial Intelligence) will sit quietly in the background-helping veterinarians read images, draft notes, and turn wearable and home-test data into simple, personal care plans. That means earlier flags for osteoarthritis, weight issues, heart or kidney changes, and skin flares, with clearer next steps for pet parents.

For LIVESTOCK, Precision Livestock Farming (PLF) brings tags, cameras, and barn sensors together to spot lameness, mastitis, respiratory disease, heat stress, and calving risks before they spread-while also guiding feed and welfare.

On the BUSINESS side, digital tools unlock practical wins: condition-based subscriptions and adherence programs, outcome-based agreements with producers and insurers, and “copilot” automations that trim busywork in pharmacovigilance (PV), medical information (MI), R&D; (research and development), and supply chain.

We’ll separate hype from helpful, share a short list of metrics that matter, and finish with a 90-day starter plan so you leave with two pilot ideas you can launch within the next 30 days.

Author:

Cal Lai

Chairman & CEO
Ask.vet



Cal Lai

Chairman & CEO
Ask.vet



Author:

Dr. Kimberly Simmons

Director Global Regulatory Affairs
Clinglobal

Dr. Kimberly Simmons

Director Global Regulatory Affairs
Clinglobal

Partnerships are critical to commercialisation journeys within the animal health market. In this session we will discuss how to evaluate the right partner for your go-to-market strategy and identify the right time to engage in that relationship.

Key takeaways will include:

  • Drivers of successful partnerships and the realisation of value
  • Factors to consider when evaluating and planning route to market

Author:

Karin Jager

President
Circa Healthcare

Karin Jager

President
Circa Healthcare

We will explore the full spectrum of market assessment, regulatory validation, and development planning required to bring innovative animal health products to market. We will examine how robust market analysis drives investor interest and attracts strategic corporate partners, while also serving as the foundation for confirming regulatory pathways and requirements.

Building on this foundation, we will outline strategies and tactics for regulatory approval, the creation of targeted development plans, and approaches to expedite product positioning and launch.

Additional insights will be shared on co-development opportunities with corporate animal health companies, offering participants a clear roadmap from concept to commercialization.

Author:

Paul Dick

President
Paul Dick & Associates

Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.

While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.

His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.

Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.

In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).

Paul Dick

President
Paul Dick & Associates

Dr Paul Dick D.V.M. M.Sc. obtained his veterinary medical degree with honours in 1984.

While working in clinical practice he completed his Masters in Immunology and Virology transitioning into the Pharmaceutical industry in 1988. Dr. Dick has over 25 years experience in the pharmaceutical space including general management and leadership roles, business development, commercialization, regulatory affairs, and product development encompassing medicinal, non-medicinal and natural health products.

His work in this sector has ranged from small “start up” companies to medium and large multi-nationals functioning in various capacities from research to COO and CEO.

Dr. Dick has worked extensively with Health Canada and the Canadian Food Inspection Agency on numerous regulatory submissions and on several Departmental Committees.

In addition he has been a recipient of the NSERC Synergy Award and has served as a peer reviewer of NSERC strategic grants. He is currently heading his own consulting firm ( Paul Dick and Associates Ltd.) and is the managing partner and president of a venture capital partnership (Vet Venture Capital Inc.).

Regenerating the System from the Pioneering Farmers’ Perspective - RASEU 2024 Insights Report
 

Aniruddha Maru

VP, Infrastructure
Standard AI

Maru is a seasoned DevOps engineer with over 15 years of experience architecting solutions that scale. He currently leads the Infrastructure team at Standard AI, where he orchestrates hybrid infrastructure that powers cutting-edge machine-learning workloads that are reshaping retail.

Aniruddha Maru

VP, Infrastructure
Standard AI

Aniruddha Maru

VP, Infrastructure
Standard AI

Maru is a seasoned DevOps engineer with over 15 years of experience architecting solutions that scale. He currently leads the Infrastructure team at Standard AI, where he orchestrates hybrid infrastructure that powers cutting-edge machine-learning workloads that are reshaping retail.

After earning bachelor’s and master’s degrees in Computer Science from Indian Institute of Technology (IIT) Bombay, Maru has conquered diverse tech stacks throughout his career - from desktop and mobile applications to 
large scale distributed systems. Over his decade-plus journey through the startup ecosystem, he's delivered breakthrough solutions including smart car IoT devices, intelligent music learning platforms, and autonomous checkout systems. Maru gravitated towards the DevOps culture, finding a passion for scalable cloud-native technologies and continuous delivery of AI workloads.